权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Sting Trafficking and Signaling Beyond Interferon

毒刺贩运和干扰素以外的信号传导

基本信息

批准号：
10591495
负责人：
Nan Yan
金额：
$ 52.64万
依托单位：
UT SOUTHWESTERN MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-04-22 至 2024-03-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10591495
关键词：
Affect Area Autoimmune Diseases Autophagocytosis Biology Calcium Calcium Signaling Cell Death Cell Survival Cell physiology Cells Chronic Development Disease Gene Expression Genes Goals Golgi Apparatus Herpesvirus 1 Human IRF3 gene In Vitro Infection Innate Immune Response Interferon Type I Interferons Ligand Binding Lipids Location Lung diseases Lysosomes Mediating Membrane Microbe Molecular Mus Mutant Strains Mice NPC1 gene Pathology Pathway interactions Phosphotransferases Physiological Physiology Pilot Projects Play Point Mutation Process Proteins Proteomics Resources Rest Role Route Signal Pathway Signal Transduction Sting Injury T-Cell Proliferation T-Lymphocyte TBK1 gene TOLLIP gene Time Vascular Diseases Vesicle Viral Physiology Work cofactor cytopenia gain of function gain of function mutation human disease in vivo infancy insight interest mouse model mutant nuclear factors of activated T-cells recruit therapeutic target trafficking transcription factor

项目摘要

Project summary STING-mediated type I interferon (IFN) signaling plays an important role in innate immune response in infection and autoimmune disease. The STING signaling pathway is unique in that it requires STING trafficking from the ER through ERGIC/Golgi to vesicles, during which time STING recruits kinase TBK1 and transcription factor IRF3 which subsequently activates IFN gene expression. STING trafficking also activates other non-IFN pathways under pathophysiological conditions such as cell death and autophagy, although the mechanism is unclear. We showed that dominant STING gain-of-function mutations constitutively activate STING trafficking in vitro and causes lung disease and T cell cytopenia independently of IFN signaling in vivo. In preliminary studies we performed a time-resolved proteomic study using STING-APEX2 and identified several cofactors at various membrane locations along the trafficking route. Our main hypothesis is that STING trafficking is a primordial way for STING to regulate multiple cellular processes including IFN and non-IFN pathways, such as calcium signaling, cell death and autophagy. The non-IFN functions of STING are likely important for human physiology because at least one such function is implicated in human disease STING-associated vasculopathy with onset in infancy (SAVI). We will study the function of STING trafficking and non-IFN functions through the following three specific aims: In Aim 1, we will study the cellular process of STING trafficking by discovering new cofactors along the trafficking route and elucidating their mechanism of action. In Aim 2, we will investigate one particular non-IFN function, the UPR, that is mediated by STING trafficking in T cells, using the dominant gain-of-function Sting- N153S mouse with active disease pathology. In Aim 3, we will broadly explore non-IFN functions of STING in a variety of physiological conditions, using a new point mutant mouse Sting-S365A, which selectively blocks STING-mediated IFN signaling while retaining normal trafficking and other signaling capabilities. Studies proposed here will address a previously understudied but important area of STING biology and reveal new functions of STING with pathophysiological relevance.

项目摘要 STING介导的I型干扰素（IFN）信号在感染的天然免疫应答中起重要作用和自身免疫性疾病。STING信号传导途径是独特的，因为它需要从细胞中运输STING。 ER通过ERGIC/高尔基体进入囊泡，在此期间STING招募激酶TBK 1和转录因子 IRF 3随后激活IFN基因表达。STING贩运也激活其他非IFN 在病理生理条件下，如细胞死亡和自噬，虽然机制是不清楚我们发现，显性STING功能获得性突变组成性激活STING运输，并且在体内独立于IFN信号传导而引起肺病和T细胞血细胞减少。在初步研究中我们使用STING-APEX 2进行了时间分辨蛋白质组学研究，并在不同的时间点鉴定了几种辅因子。沿着贩运路线的膜位置。我们的主要假设是，STING贩运是一种原始的方式，对于STING调节多种细胞过程，包括IFN和非IFN途径，如钙信号传导，细胞死亡和自噬。STING的非IFN功能可能对人体生理学很重要，因为至少有一种这样的功能与婴儿期发病的人类疾病STING相关血管病变有关（SAVI）.我们将通过以下三个具体步骤来研究STING的运输功能和非IFN功能目的：在目的1中，我们将通过发现新的辅因子沿着STING运输的细胞过程，贩运路线并阐明其作用机制。在目标2中，我们将研究一种特定的非IFN 功能，UPR，这是由T细胞中的STING运输介导的，使用显性功能获得性Sting- 具有活动性疾病病理学的N153 S小鼠。在目标3中，我们将广泛地探索STING的非IFN功能，各种生理条件下，使用一种新的点突变小鼠Sting-S365 A，它选择性地阻断 STING介导的IFN信号传导，同时保留正常的运输和其他信号传导能力。研究这里提出的将解决以前研究不足，但STING生物学的重要领域，并揭示新的 STING的功能与病理生理学相关性。